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Abstract
Oxidative stress plays a critical role in the pathophysiology of cardiac failure, including the modulation of neovascularization
following myocardial infarction (MI). Redox molecules thioredoxin (Trx) and glutaredoxin (Grx) superfamilies actively
maintain intracellular thiol-redox homeostasis by scavenging reactive oxygen species. Among these two superfamilies, the
pro-angiogenic function of Trx-1 has been reported in chronic MI model whereas similar role of Grx-1 remains uncertain. The
present study attempts to establish the role of Grx-1 in neovascularization and ventricular remodeling following MI. Wild-
type (WT) and Grx-1 transgenic (Grx-1
Tg/+) mice were randomized into wild-type sham (WTS), Grx-1
Tg/+ Sham (Grx-1
Tg/+S),
WTMI, Grx-1
Tg/+MI. MI was induced by permanent occlusion of the LAD coronary artery. Sham groups underwent identical
time-matched surgical procedures without LAD ligation. Significant increase in arteriolar density was observed 7 days (d)
after surgical intervention in the Grx-1
Tg/+MI group as compared to the WTMI animals. Further, improvement in myocardial
functional parameters 30 d after MI was observed including decreased LVIDs, LVIDd, increased ejection fraction and,
fractional shortening was also observed in the Grx-1
Tg/+MI group as compared to the WTMI animals. Moreover, attenuation
of oxidative stress and apoptotic cardiomyocytes was observed in the Grx-1
Tg/+MI group as compared to the WTMI animals.
Increased expression of p-Akt, VEGF, Ang-1, Bcl-2, survivin and DNA binding activity of NF-kB were observed in the Grx-1
Tg/
+MI group when compared to WTMI animals as revealed by Western blot analysis and Gel-shift analysis, respectively. These
results are the first to demonstrate that Grx-1 induces angiogenesis and diminishes ventricular remodeling apparently
through neovascularization mediated by Akt, VEGF, Ang-1 and NF-kB as well as Bcl-2 and survivin-mediated anti-apoptotic
pathway in the infarcted myocardium.
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Introduction
Glutaredoxin-1 (Grx-1) is a relatively abundant, small (12 kDa)
cytosolic enzyme that regulates protein mixed disulfides through
their reduction by GSH (S-glutathiolated proteins; R–SSG).
Unlike Trx-1, Grx-1 does not catalyze the reduction of sulfenic
acid or intra- and intermolecular disulfides, thereby efficiently
catalyzing the reduction of R-SSG in the presence of NADPH and
glutathione reductase [1,2]. Several lines of evidence indicate that
Grx-1 is cardioprotective by attenuating oxidant-induced cell
death and apoptosis [3,4,5]. The extent of cardiomyocyte
apoptosis is enhanced in the Grx-1 knockout mice after ischemia
and is decreased in mice overexpressing Grx-1 [3]. The activities
of several mediators of apoptosis like procaspase-3 and p65 have
been reported to be modulated by reversible glutathionylation
under the control of Grx-1 [6].
Overexpression of Grx in H9c2 cardiomyocytes is cytoprotec-
tive diminishing H2O2-induced apoptosis likely through redox
regulation of Akt [4]. Similarly, Grx overexpression in HEK cells
is protective and enhances the cell survival after glucose
deprivation via Grx-1 complex formation with ASK1 [7].
Furthermore, elevated Grx-1 expression has been found in human
coronary arteries, possibly by protecting the endothelial cells from
oxidative stress in both normal and atherosclerotic vessels [8].
However, the pro-angiogenic role of endogenous Grx-1 has not
been reported in myocardial infarction (MI). Hence, we have
hypothesized that Grx-1 acts as pro-angiogenic molecule and
lowered activity of this important intracellular redox regulator
during ischemic stress results in the inhibition of neovasculariza-
tion.
Targeted promotion of new functional and mature vessels
capable of restoring blood flow to ischemic tissues is an attractive
option in the treatment of ischemic vascular disease [9].
Accumulating evidence shows that cytokines such as VEGF and
Ang-1 and transcription factors like hypoxia-inducible factor-1a
act as potential therapeutic pro-angiogenic molecules in experi-
mental models [10]. Our laboratory has recently shown that Trx-1
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[12] further corroborating our earlier work which reveals that
redox imbalance during ischemic stress inhibits angiogenesis
[12,13].
Angiogenesis is known to be regulated by the mutual interplay
between the vascular endothelial growth factor (VEGF)/VEGF
receptor (VEGFR) complex and angiopoietins/Tie-2 families [14].
As one of the most potent stimulants of neovascularization, VEGF
functions by promoting the expression of other growth factors in
endothelial cells [15]. Additionally, Ang-1 is a secreted glycopro-
tein which is essential for endothelial integrity and vessel
maturation via Tie-2 phosphorylation [16,17], while VEGF is
required to initiate the formation of immature vessels [18]. Ang-1
overexpressing mice appear to form larger and more mature
neovessels following ischemic injury [19]. Furthermore, as a result
of its antioxidant functions, Grx-1 may play a crucial role in
regulating the Akt/Bcl-2 survival pathway which plays a central
signaling node involved in cell growth, proliferation, differentia-
tion, apoptosis, and angiogenesis [20]. Bcl-2 protein belongs to the
family of molecules with pro-apoptotic and anti-apoptotic activity
[21]. Diminished Bcl-2 level has been reported in ischemic
myocardium in vivo [22]. Under similar conditions Bax protein
level is found to be upregulated [22,23].
In view of the robust ventricular remodeling observed after
myocardial infarction, the role of oxidative stress–mediated
reduction in myocardial angiogenesis and the antioxidative and
growth regulatory action of Grx-1, we have hypothesized that
overexpression of Grx-1 in the myocardium would be beneficial in
promoting neovascularization and preventing subsequent ventric-
ular remodeling after myocardial infarction through upregulation
of pro-angiogenic and anti-apoptotic molecules.
Materials and Methods
Experimental Animals
Animal experiments were performed following the guidelines in
accordance with the Guide for the Care and Use of Laboratory
Animals prepared by the National Academy of Sciences and
published by the National Institutes of Health (Publication No. 85-
23, revised 1985). The experimental protocol was examined and
approved by the Institutional Animal Care Committee (ACC #
2009-518) of UCONN Health Center (Farmington, CT, USA).
Eight to 12 week-old male Grx-1
Tg/+ overexpressing C57BL/6
background mice and respective wild-type mice were used for the
study. Glutaredoxin 1 (Grx-1) transgenic mice carrying a human
Grx-1 transgene driven by the human b-actin promoter were
generated at Wayne State University (data not shown). The
genotype of each animal was confirmed by polymerase chain
reaction analysis on purified ear DNA. Expression of the human
Grx-1 transgene in different organs of transgenic mice was shown
by Western blot analysis (Fig. 1).
Experimental design
Eight to 12-week-old male Grx-1
Tg/+ and respective wild-type
mice were randomized into four groups: (1) wild-type sham
(WTS); (2) Grx-1
Tg/+ Sham (Grx-1
Tg/+S); (3) wild-type MI
(WTMI) and 4) Grx-1
Tg/+ MI (Grx-1
Tg/+MI). MI was induced
by permanent left anterior descending (LAD) coronary artery
ligation. Sham groups underwent identical time-matched surgical
procedure without coronary ligation. Cardiomyocyte apoptosis
and oxidative stress were measured 24 h after surgical interven-
tion. The protein expression profile for VEGF, Ang-1, Bcl-2 and
survivin was determined in the left ventricular tissue (risk area/
Figure 1. Characterization of Grx-1 transgenic mice. Expression of human Grx-1 protein in brain, heart, liver, lung and kidney of Grx-1
transgenic mice was determined by Western blot analysis. (+/+) denotes wild-type mice and (Tg/+) denotes Grx-1 transgenic mice. The anti-human
Grx-1 antibodies used in the study show no cross-reactivity with the endogenous mouse Grx-1 protein.
doi:10.1371/journal.pone.0034790.g001
Figure 2. Effect of Grx-1 overexpression on arteriolar density
after MI. A, Representative digital micrographs showing arteriolar
density/a-smooth muscle actin immuno-staining in different experi-
mental groups 7 days after surgical intervention. B, Quantitative analysis
of arteriolar density, in counts/mm
2. The values are mean6SEM of 3–6
animals per group. Arteriolar density was found to be significantly
increased in Grx-1
Tg/+MI compared to WTMI. WTS indicates wild-type
sham; Grx-1
Tg/+S, Grx-1 transgenic sham; WTMI, wild-type animals
subjected to MI; Grx-1
Tg/+MI, Grx-1 transgenic animals subjected to MI.
*, P#0.05 Grx-1
Tg/+MI vs. WTMI.
doi:10.1371/journal.pone.0034790.g002
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PLoS ONE | www.plosone.org 2 April 2012 | Volume 7 | Issue 3 | e34790Figure 3. Effect of Grx-1 overexpression on cardiac function after MI. A, The quantitative data of left ventricular internal diameter in diastole
(LVIDd); B, The quantitative data of left ventricular internal diameter in systole (LVIDs); C, ejection fraction; and D, fractional shortening. The data
demonstrate more pronounced ventricular dysfunction in the WTMI compared to WTS and Grx-1
Tg/+S. Grx-1 overexpression significantly improved
functional parameters compared to the WTMI. Values are mean 6 SEM (n=4 per group). WTS indicates wild-type sham; Grx-1
Tg/+S, Grx-1 transgenic
sham; WTMI, wild-type animals subjected to MI; Grx-1
Tg/+MI, Grx-1 transgenic animals subjected to MI. *, P#0.05 Grx-1
Tg/+MI vs. WTMI.
doi:10.1371/journal.pone.0034790.g003
Figure 4. Effect of Grx-1 overexpression on the oxidative stress and cardiomyocyte apoptosis after MI. A, Representative digital
micrographs showing cardiomyocyte apoptosis in hearts of Grx-1
Tg/+MI and WTMI groups. B, Quantitative analysis of cardiomyocyte apoptosis after
MI from 3–5 animals, in counts/100 high-power field (HPF). The apoptotic cardiomyocytes are significantly reduced in Grx-1
Tg/+MI compared to WTMI.
C, Representative Western blots showing the expression of Bcl-2, Bax, and their corresponding loading control-GAPDH in different groups. D,
Oxidative stress (by dihydroethidium staining for O2
2 production); three representative images/group show dihydroethidium-stained myocardial
sections 24 h after MI. Scale bar 50 mm. Grx-1 transgenic animals subjected to MI resulted in a significant reduction in oxidative stress compared to
WT animal myocardium. Dihydroethidium fluorescence was observed from 5 images per heart and 3 to 4 hearts per group. WTMI indicates wild-type
animals subjected to MI; Grx-1
Tg/+MI, Grx-1 transgenic animals subjected to MI. *, P#0.05 Grx-1
Tg/+MI vs. WTMI.
doi:10.1371/journal.pone.0034790.g004
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phosphorylation of Akt (p-AKT) and NF-kB DNA binding activity
were measured 8 h after surgical intervention. Arteriolar density
was determined 7 d after surgery. Ventricular remodeling/cardiac
function was assessed by echocardiography 30 d after surgery.
Surgical procedures
Mice were anesthetized with ketamine (100 mg/kg, ip) and
xylazine (10 mg/kg, ip) dissolved in physiological saline, then
orally intubated with a 22G IV catheter, and ventilated with a
rodent respirator (Harvard Apparatus, Hilliston, USA). Hearts
were then exposed through a left lateral thoracotomy. MI was
initiated by permanent LAD ligation with 8-0 polypropylene
suture viewed under a stereo zoom dissection microscope. The
lungs were inflated by positive end-expiratory pressure and the
chest was closed with 6.0 nylon suture. After surgery, the analgesic
buprenorphine (0.1 mg/kg, sc) was given for analgesia and the
animals were weaned from the respirator and then placed on a
heating pad for recovery [11].
Arteriolar density
Arteriolar density was measured 7 d after surgery by immuno-
histochemistry according to our previously published procedure
[11].
Echocardiography measurements
Echocardiography was performed 30 d after surgical interven-
tion to evaluate cardiac function according to our previously
published procedure [11,12].
Reactive Oxygen Species (ROS) detection in the heart
Mice were sacrificed 24 h after MI and horizontal heart tissue
sections collected between the point of ligation and the apex were
harvested and embedded in optimum cutting temperature (OCT)
medium. Superoxide production in hearts 24 h after MI was
detected by dihydroethidium (DHE) staining (Invitrogen, Carlsbad,
CA, USA). Frozen heart sections (10 mM) were incubated with
10 mM DHE for 45 min at 37uC in a humidified chamber
protected from light. Fluorescent images were captured using Zeiss
LSM510Meta confocal laser scanning microscopy. The DHE
fluorescence intensity was observed from 5 images/heart and 3 to
4 hearts/group. All images were processed equally and subjected
to background corrections [24].
Cardiomyocyte apoptosis
Immunohistochemical detection of apoptotic cells was carried
out using TUNEL reaction using an In Situ Cell Death Detection
Kit and fluorescein as per the kit protocol (Roche Diagnostics,
Mannheim, Germany). The cardiomyocytes were identified with
mouse monoclonal sarcomeric actin (Sigma, St. Louis, MO)
followed by staining with Alexa Fluor 555 donkey anti-mouse IgG
(1:200 dilution, Invitrogen, Carlsbad, CA). Following examination
of sections, images were captured using a confocal laser Zeiss LSM
510 Meta microscope. The number of TUNEL-positive cardio-
myocytes was counted on 100 high-power fields (HPF) [11,12].
Western blot analysis
To determine the expression of Grx-1, p-Akt, VEGF, Ang-1
Bcl-2, Bax and survivin, standard SDS–PAGE Western blot
technique was performed as described previously [11,12].
Cytosolic and nuclear proteins were prepared according to the
kit protocol of the CelLytic NuCLEAR Extraction Kit obtained
from Sigma, St. Louis, MO. Protein concentration was deter-
mined using a bicinchoninic acid protein assay kit (Pierce,
Rockville, IL). The proteins were separated on 10% SDS-
polyacrylamide gels for p-Akt (Serine 473) (Cell Signaling
Technologies, Danvers, MA), Ang-1, Bcl-2, Bax (Santa Cruz
Biotechnology, Santa Cruz, CA), VEGF (R & D Systems,
Minneapolis, MN) and on 14% polyacrylamide gels for survivin
(Abcam, Cambridge, MA) & Grx-1 (Santa Cruz Biotechnology,
Santa Cruz, CA).
Gel-Shift analysis for NF-kB DNA binding activity
Gel-shift was performed as per the manufacturer’s Instruction
(Gel Shift Assay System from Promega). In brief 7 mg of the
nuclear extracts following their incubation for 20 min at room
temperature with
32P end-labeled oligonucleotides containing the
putative NF-kB( 5 9-AGTTGAGGGGACTTTCCCAGGC-39)
(Promega, Madison, WI, USA) binding site was used. HeLaScribe
Nuclear Extract (Promega, Madison, WI, USA) was used as
positive control. Reaction products were resolved on 5% non-
denaturing polyacrylamide gel [13].
Figure 5. Effect of Grx-1 overexpression on the phosphoryla-
tion of Akt (p-AKT) after MI. Representative Western blots show the
expression of p-Akt (A). Bar graph (B) represent the quantitative analysis
and difference in the expression of p-Akt between groups, after they
were normalized with corresponding non-phosphorylated protein
controls, respectively in arbitrary units. The values are mean6SEM
(n=4–5 from each group). There was a significant increase in the
expression of p-Akt in Grx-1
Tg/+MI compared to the WTMI. WTS
indicates wild-type sham; Grx-1
Tg/+S, Grx-1 transgenic sham; WTMI,
wild-type animals subjected to MI; Grx-1
Tg/+MI, Grx-1 transgenic animals
subjected to MI. *, P#0.05 Grx-1
Tg/+MI vs. WTMI.
doi:10.1371/journal.pone.0034790.g005
Grx-1, Molecule for Myocardial Angiogenesis
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Results were expressed as mean 6 SEM. One way ANOVA
followed by Newman-Keuls multiple comparison test or unpaired
‘‘t’’ test (Graph Pad Prism Software) was carried out to determine
differences between the mean values of all groups. The results
were considered significant at P#0.05.
Results
Characterization of Grx-1 transgenic mice
Western blot analysis revealed expression of the human Grx-1
protein in brain and heart of the Grx-1 transgenic mice (Fig. 1).
The level of endogenous glyceraldehyde 3-pohsphate dehydroge-
nase (GAPDH) protein was also determined to ensure equal
loading of proteins in the lysates that are prepared from the same
organs of wild-type and Grx-1 transgenic mice. It should be noted
that the extent of GAPDH protein is different in various organs
due to the difference in the mRNA level [25]. We therefore,
compared the GAPDH protein level in the same tissue (organ)
sample between wild-type and Grx-1 transgenic mice.
Grx-1 overexpression promotes neovascularization by
increasing arteriolar density after myocardial infarction
Increased arteriolar density was observed in the Grx-1
Tg/+MI
group as compared to the WTMI group (28 vs 19; counts/mm
2)
(n=3–6/group) (Fig. 2A and B). There were no significant
differences in arteriolar density between the WTS and Grx-1
Tg/+S
groups. These results demonstrated that Grx-1 enhances the
neovascularization by increasing the arteriolar density during
ischemic stress.
Post-ischemic ventricular remodeling is prevented by
Grx-1 overexpression
Left ventricular functional parameters were studied by echo-
cardiography 30 days after coronary ligation. Left ventricular
function was preserved in WTS as assessed by ejection fraction
(WTS vs. WTMI: 67 vs. 42%) (Fig. 3C) and fractional shortening
(WTS vs. WTMI: 36 vs 20%) (Fig. 3D) in comparison to the
WTMI group. In mice overexpressing Grx-1, functional param-
eters significantly improved following MI when compared to the
WTMI group (ejection fraction- Grx-1
Tg/+MI vs. WTMI: 53 vs
42%; fractional shortening- Grx-1
Tg/+MI vs. WTMI: 27 vs 20%).
Furthermore, the WTMI group exhibited a progressive increase in
diastolic left ventricular internal diameter (LVIDd) (Fig. 3A) and
systolic LVID (LVIDs) (Fig. 3B) as compared to both the WTS,
and Grx-1
Tg/+MI LVIDs (Grx -1
Tg/+MI vs. WTMI: 2.9 vs
3.6 mm) and LVIDd (Grx-1
Tg/+MI vs. WTMI: 4.0 vs 4.5 mm) as
compared to the WTMI group. Therefore, Grx-1 overexpression
was associated with a progressive and significant increase in LV
function as compared to the wild-type animals subjected to MI.
Grx-1 overexpression attenuates oxidative stress and
cardiomyocyte apoptosis and decreases Bax/Bcl-2 ratio
after myocardial infarction
The extent of ROS-mediated oxidative stress was determined
24 h after MI by measuring superoxide anion (O2
_) formation by
utilizing dihydroethidium staining (n=3 to 4 per group; Fig. 4D).
Myocardial ROS levels were significantly decreased in the Grx-
1
Tg/+MI group as compared to the WTMI group, suggesting that
Grx-1 acted as an antioxidant during ischemic stress. The extent of
cardiomyocyte apoptosis (Fig. 4A), detected by using TUNEL
staining in conjunction with a-sarcomeric actin significantly
decreased in the Grx-1
Tg/+MI group when compared to the
WTMI (261 vs 622; counts/100 HPF) (Fig. 4B). Hence, to
determine whether the extent of decrease in apoptosis as observed
by TUNEL staining was accompanied by a change of the ratio
between Bax and Bcl-2, we performed Western blot analysis of
both Bax and Bcl-2 proteins.
Western blot analysis showed a relative increase in Bcl-2 and
decrease in Bax expression in both the Grx-1
Tg/+S and
Grx-1
Tg/+MI groups as compared to the respective wild-type
sham and MI groups. The Bax/Bcl-2 ratio was found to be
Figure 6. Effect of Grx-1 overexpression on VEGF, Ang-1 and survivin expression after MI. Representative Western blots showing the
expression of VEGF, Ang1 and survivin, and their corresponding loading control-GAPDH in different groups. Western blot analysis revealed increased
VEGF (A), Ang1, (B) and survivin (C) expression in Grx-1
Tg/+MI compared to the WTMI. Numbers below the bands represent the average-fold change
compared to WTS from 3–5 independent experiments. WTS indicates wild-type sham; Grx-1
Tg/+S, Grx-1 transgenic sham; WTMI, wild-type animals
subjected to MI; Grx-1
Tg/+MI, Grx-1 transgenic animals subjected to MI.
doi:10.1371/journal.pone.0034790.g006
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which was similar to increased extent of apoptosis as determined
by the TUNNEL staining. Overexpression of Grx-1 showed
decrease in Bax/Bcl-2 ratio when compared to the WTMI group,
which correlated with decreased apoptosis which was also
comparable to the results obtained by TUNEL staining. These
results suggested that Grx-1 acted as an anti-apoptotic molecule
during ischemic stress.
Grx-1 overexpression increases phosphorylation of Akt
after MI
The expression of p-Akt (Fig. 5), measured 8 h after coronary
ligation significantly increased in the Grx-1
Tg/+MI group as
compared to the WTMI group, indicating the mechanism of
action Grx-1 during ischemic stress probably through Akt
signaling pathway.
Grx-1 overexpression increases expression of VEGF, Ang-
1, and survivin in ischemic myocardium
The expression of VEGF (Fig. 6A), Ang-1 (Fig. 6B) and survivin
(Fig. 6C) considerably increased in the Grx-1
Tg/+MI group as
compared to the WTMI group 4 d following infarction indicating
the angiogenic and anti-apoptotic roles of Grx-1 during ischemic
stress involving Akt/VEGF/Ang-1/Bcl-2/Bax and survivin.
Grx-1 overexpression increases DNA binding activity of
NF-kB during ischemic stress
The role of Grx-1 on DNA binding activity of redox
transcription factor NF-kB during ischemic stress was evaluated
by EMSA/gel shift analysis. The DNA binding activity of NF-kB
was significantly increased in the Grx-1
Tg/+MI compared to the
WTMI animals (Fig. 7), suggesting the possible role of Grx-1 in
influencing the NF-kB expression followed by nuclear transloca-
tion and its DNA binding activity during ischemic stress.
Discussion
Our findings suggested that, in response to MI, Grx-1: (i)
promoted neovascularization through significant improvement in
arteriolar density in the border zones; (ii) reduced ventricular
remodeling; (iii) increased the expression of VEGF and Ang-1 (iv)
increased Akt and NF-kB expression; (v) attenuated oxidative
stress, reduced cardiomyocyte apoptosis and increased expression
of anti-apoptotic factors Bcl-2 and survivin but decreased the
expression of Bax. These current data strongly suggested that Grx-
1 overexpression promotes cardiac repair after MI by increasing
neovascularization and reducing ventricular remodeling through
pro-angiogenic and anti-apoptotic mechanisms.
Cardiomyocyte apoptosis, subsequent ventricular remodeling,
and heart failure represent important areas for therapeutic targets
in cardiovascular medicine [26,27,28]. Strong evidence has
accumulated that ROS produced during ischemic stress triggers
apoptosis through a variety of mechanisms [12]. The present study
demonstrated that Grx-1 overexpression significantly decreases the
ROS production and cardiomyocyte apoptosis leading to
improved functional and biochemical outcomes when compared
to the infarcted hearts normally expressing this important
intracellular redox regulator. The study also showed overexpres-
sion of Grx-1 increased both Bcl-2 and survivin and further
decreased Bax/Bcl-2 ratio, which has been proposed as an
important biomarker of myocardial survibility or index of
apoptosis [23,29]. We also observed that NF-kB, an important
cellular regulator in normal and disease states [30] which has been
implicated in the cardioprotective effects of preconditioning [31],
was activated by overexpression of Grx-1. Its signaling pathways
are reported to be inhibited by S-glutathionylation, thus
representing other potential targets for regulation by Grx-1 [32].
Furthermore, alterations in Grx-1 activity have been linked to
changes in NF-kB activity in rodent airway [33] and human
kidney [34] cell lines. By demonstrating increased expression and
DNA binding activity of NF-kB in the Grx-1
Tg/+MI hearts, our
current findings suggested that the decrease in apoptosis as
observed in these hearts might result from both the direct
antioxidant activity of Grx-1 as well as through the anti-apoptotic
effects of NF-kB, Bcl-2 and survivin.
The mechanistic link between the inhibition of oxidative stress
and cardioprotection by Grx-1 overexpression remains elusive.
Figure 7. Effect of Grx-1 overexpression on DNA binding
activity of NF-kB during ischemic stress. Gel-shift analysis showed
increased nuclear translocation and DNA binding activity of redox
transcription factor NF-kB in Grx-1
Tg/+MI compared to WTMI (n=3 from
each group). WTS indicates wild-type sham; Grx-1
Tg/+S, Grx-1 transgenic
sham; WTMI, wild-type animals subjected to MI; Grx-1
Tg/+MI, Grx-1
transgenic animals subjected to MI; NS, non-specific binding.
doi:10.1371/journal.pone.0034790.g007
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signaling [35]. It has been demonstrated that antioxidant
treatment significantly reduces microvascular density in the
infarcted myocardium [36], indicating that indiscriminate removal
of oxygen-derived free radicals perturbs an appropriate redox
condition necessary for angiogenesis and cell survival. A growing
body of evidence suggests that S-nitrosylation plays a crucial role
in angiogenesis and cardioprotection [37,38]. Therefore, it is
anticipated that overexpression of Grx-1 inhibits formation of
protein mixed disulfides by eliminating oxidative stress but
maintains nitroso-redox balance for S-nitrosylation of protein
thiols leading to activation of crucial proteins involved in the
angiogenesis and cardioprotection.
Endothelial tip cells sprouting at the leading edge of capillaries
near the infarct zone recognize VEGF across a gradient and direct
the angiogenic process towards ischemic areas [39,40]. New vessel
formation is also promoted by Ang-1/Tie-2 signaling through
vessel maturation and the maintenance of endothelial integrity
[17,19,41]. Ang-1 is also required for further maturation and
remodeling of VEGF-initiated immature vessels during post-
ischemic angiogenesis [14,41] and overexpression of Ang-1 in
transgenic mice has been reported to result in larger and more
mature neovessel formation [19]. In our study, Grx-1 overexpres-
sion significantly increased the expression of both VEGF and Ang-
1 as a result of ischemic stress resulting in an increase in arteriolar
density reflecting the enhanced degree of angiogenesis.
A growing body of evidence indicates that ischemia-mediated
oxidative stress modulates Akt expression and depresses the
production of downstream angiogenic factors [42]. Increased
Akt expression inhibits the catalytic activity of GSK-3b, thereby
increasing the nuclear translocation of b-catenin and expression of
its target angiogenic and anti-apoptotic genes [20]. Along with the
increased VEGF and Ang-1 expression, we also observed the
increased Akt-signaling in the Grx-1 transgenic animals as
compared to the WT mice possibly as a result of reduced
oxidative stress [42,43] mitigated by Grx-1 overexpression.
As such, our current study suggested that Grx-1 reduced
oxidative stress resulting in activation of the Akt pathway thereby
up-regulating the expression of both VEGF and Ang-1 which
subsequently leading to enhanced angiogenesis and neovascular-
ization. The increased vascular density might have also resulted in
increased regional perfusion, potentially accounting for the
observed improvement in the left ventricular function.
In conclusion, the current findings indicated that redox
imbalance inhibited normal angiogenic mechanisms which are
attenuated by Grx-1 overexpression. Prompt normalization of the
intracellular oxidative microenvironment following ischemic injury
to the myocardium may result in lowering cell death and induction
of neovascularization and vessel maturation with attendant effects
on subsequent ventricular remodeling. Therapeutic approaches
which enhance the expression of the antioxidant, Grx-1, may
result in clinically-relevant strategies in the treatment of ischemic
cardiovascular diseases.
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